Kailera Therapeutics, Inc. (KLRA)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Insider purchase
    Kaplan Andrew T. (director) bought $134.4M of stock
  2. Insider purchase
    BCPE Perseus Investor, LP (ten_percent_owner) bought $134.4M of stock
  3. Insider purchase
    Kaplan Andrew T. (director) bought $134.4M of stock
  4. Insider purchase
    BCLS Fund IV Investments GP, LLC (ten_percent_owner) bought $25.0M of stock
  5. Insider buying cluster
    5 insiders bought $326.8M within 14 days
  6. Insider purchase
    Koppel Adam (director) bought $25.0M of stock
  7. Insider purchase
    Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences IV General Partner, LLC; Bain Capital Life Sciences Fund IV, L.P.; BCLS Fund IV Investments GP, LLC; BCLS Fund IV Investments, L.P. (ten_percent_owner) bought $25.0M of stock
  8. Insider purchase
    Koppel Adam (director) bought $25.0M of stock
  9. Insider purchase
    RTW INVESTMENTS, LP (ten_percent_owner) bought $8.0M of stock

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-06-09Renaud Ronald C JRdirectorM38,0945.25$199,994
2026-06-09Renaud Ronald C JRdirectorM38,0945.25$199,994
2026-04-20Kaplan Andrew T.directorP8,398,43816$134,375,008
2026-04-20Kaplan Andrew T.directorC17,857,143
2026-04-20Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences IV General Partner, LLC; Bain Capital Life Sciences Fund IV, L.P.; BCLS Fund IV Investments GP, LLC; BCLS Fund IV Investments, L.P.ten percent ownerP1,562,50016$25,000,000
2026-04-20Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences IV General Partner, LLC; Bain Capital Life Sciences Fund IV, L.P.; BCLS Fund IV Investments GP, LLC; BCLS Fund IV Investments, L.P.ten percent ownerC4,145,768
2026-04-20Bain Capital Life Sciences Investors, LLC; Bain Capital Life Sciences IV General Partner, LLC; Bain Capital Life Sciences Fund IV, L.P.; BCLS Fund IV Investments GP, LLC; BCLS Fund IV Investments, L.P.ten percent ownerC16,875,000
2026-04-20Koppel AdamdirectorP1,562,50016$25,000,000
2026-04-20Koppel AdamdirectorC4,145,768
2026-04-20Koppel AdamdirectorC16,875,000
2026-04-20BAIN CAPITAL INVESTORS LLC; Bain Capital XIV General Partner, LLC; Bain Capital Fund XIV, L.P.; BCPE Perseus Investor GP, LLC; BCPE Perseus Investor, LPten percent ownerP8,398,43816$134,375,008
2026-04-20BAIN CAPITAL INVESTORS LLC; Bain Capital XIV General Partner, LLC; Bain Capital Fund XIV, L.P.; BCPE Perseus Investor GP, LLC; BCPE Perseus Investor, LPten percent ownerC17,857,143
2026-04-20Jiangsu Hengrui Pharmaceuticals Co., Ltd.ten percent ownerC2,034,133
2026-04-20Jiangsu Hengrui Pharmaceuticals Co., Ltd.ten percent ownerC9,477,719
2026-04-20RTW INVESTMENTS, LP; WONG RODERICKten percent ownerP500,00016$8,000,000
2026-04-20RTW INVESTMENTS, LP; WONG RODERICKten percent ownerC10,276,820
2026-04-20RTW INVESTMENTS, LPten percent ownerC10,276,820
2026-04-20RTW INVESTMENTS, LPten percent ownerP500,00016$8,000,000
2026-04-20Jiangsu Hengrui Pharmaceuticals Co., Ltd.ten percent ownerC2,034,133
2026-04-20Jiangsu Hengrui Pharmaceuticals Co., Ltd.ten percent ownerC9,477,719
2026-04-20BCPE Perseus Investor, LPten percent ownerC17,857,143
2026-04-20BCPE Perseus Investor, LPten percent ownerP8,398,43816$134,375,008
2026-04-20Koppel AdamdirectorC4,145,768
2026-04-20Koppel AdamdirectorP1,562,50016$25,000,000
2026-04-20Koppel AdamdirectorC16,875,000
2026-04-20BCLS Fund IV Investments GP, LLCten percent ownerC16,875,000
2026-04-20BCLS Fund IV Investments GP, LLCten percent ownerP1,562,50016$25,000,000
2026-04-20BCLS Fund IV Investments GP, LLCten percent ownerC4,145,768
2026-04-20Kaplan Andrew T.directorP8,398,43816$134,375,008
2026-04-20Kaplan Andrew T.directorC17,857,143

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings